side effects glp 1 agonist The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions Clinical Recommendations to Manage Gastrointestinal

Koppes, E

By targeting overlapping yet distinct hormonal pathways, dual incretin therapies aim to amplify weight loss, enhance insulin sensitivity, and improve overall metabolic outcomes beyond what is achievable with GLP-1 receptor agonists alone

Do not use Saxenda if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Past performance in clinical trials does not guarantee individual results

Ethics statement The studies involving humans were approved by the Institutional Review Board at the University of Texas Health Science Center at San Antonio

10.1038/ajg.2010.363 56